Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Sándor, Szántó"'
Autor:
Boglárka Soós, Attila Hamar, Anita Pusztai, Monika Czókolyová, Edit Végh, Szilvia Szamosi, Zsófia Pethő, Katalin Gulyás, György Kerekes, Sándor Szántó, Gabriella Szűcs, Uwe Christians, Jelena Klawitter, Tamás Seres, Zoltán Szekanecz
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionRheumatoid arthritis (RA) has been associated with changes in lipid, arginine and NO metabolism with increased cardiovascular (CV) risk. The aim of this study is to evaluate the effect of tofacitinib, a Janus kinase (JAK) inhibitor, on ar
Externí odkaz:
https://doaj.org/article/a6061826902b48d89056abe612f96e15
Autor:
Balázs Juhász, Katalin Gulyás, Ágnes Horváth, Edit Végh, Anita Pusztai, Ágnes Szentpétery, Zsófia Pethő, Nóra Bodnár, Attila Hamar, Levente Bodoki, Harjit Pal Bhattoa, Éva Szekanecz, Katalin Hodosi, Andrea Domján, Szilvia Szamosi, Csaba Horváth, Sándor Szántó, Gabriella Szűcs, Hennie G. Raterman, Willem F. Lems, Oliver FitzGerald, Zoltán Szekanecz
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Introduction Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are associated with osteoporosis. There have not been many peripheral quantitative computed tomography (QCT) studies in patients receiving biologics. We assessed volumetr
Externí odkaz:
https://doaj.org/article/854910d3b56d4171a2efafc3c61464fd
Autor:
Anita Pusztai, Attila Hamar, Monika Czókolyová, Katalin Gulyás, Ágnes Horváth, Edit Végh, Zsófia Pethő, Szilvia Szamosi, Emese Balogh, Nóra Bodnár, Levente Bodoki, Ágnes Szentpétery, Harjit Pal Bhattoa, György Kerekes, Balázs Juhász, Éva Szekanecz, Katalin Hodosi, Andrea Domján, Sándor Szántó, Hennie G. Raterman, Willem F. Lems, Zoltán Szekanecz, Gabriella Szűcs
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Cardiovascular (CV) disease and osteoporosis (OP) have been associated with rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Bone and vascular biomarkers and parameters along with the effect of 1-year anti-TNF therapy on these mark
Externí odkaz:
https://doaj.org/article/81ecefe24d80492490c1152dcc6c8038
Autor:
SÁNDOR, SZÁNTÓ
Publikováno v:
Immunology Quaterly / Immunológia Szemle; 2024, Vol. 16 Issue 2, p49-53, 5p
Autor:
Boglárka Soós, Miklós Fagyas, Ágnes Horváth, Edit Végh, Anita Pusztai, Monika Czókolyová, Alexandra Csongrádi, Attila Hamar, Zsófia Pethő, Nóra Bodnár, György Kerekes, Katalin Hodosi, Éva Szekanecz, Szilvia Szamosi, Sándor Szántó, Gabriella Szűcs, Zoltán Papp, Zoltán Szekanecz
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
IntroductionAngiotensin-converting enzyme (ACE) and ACE2 have been implicated in the regulation of vascular physiology. Elevated synovial and decreased or normal ACE or ACE2 levels have been found in rheumatoid arthritis (RA). Very little is known ab
Externí odkaz:
https://doaj.org/article/9be3049328d844bfb17fcc4b90d78fb4
Autor:
Zoltan Szekanecz, Gabriella Szücs, Boglarka Soos, Attila Hamar, Szilvia Szamosi, Sándor Szántó, Edit Végh, Anita Pusztai, György Kerekes, Katalin Hodosi, Zsolt Hascsi, Monika Czókolyová, Zsófia Pethő, Katalin Gulyás, Éva Szekanecz, Tamás Seres
Publikováno v:
RMD Open, Vol 7, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/e3f6b6623c4749148a1889776b2c2f94
Autor:
Szilárd Póliska, Timea Besenyei, Edit Végh, Attila Hamar, Anita Pusztai, Andrea Váncsa, Nóra Bodnár, Szilvia Szamosi, Mária Csumita, György Kerekes, Zoltán Szabó, Zoltán Nagy, Gabriella Szűcs, Sándor Szántó, Gábor Zahuczky, László Nagy, Zoltán Szekanecz
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-11 (2019)
Abstract Objectives Impaired vascular pathophysiology and increased cardiovascular (CV) mortality are associated with rheumatoid arthritis (RA). To date, no genomic analysis of RA- and RA treatment-related vascular pathophysiology has been published.
Externí odkaz:
https://doaj.org/article/269cc2dae60e4a5dbd34ea4501932adc
Autor:
Daniela Opris-Belinski, Shandor F Erdes, Simeon Grazio, Ladislav Šenolt, Maja Hojnik, Orsolya Nagy, Diana Marina, Sándor Szántó
Publikováno v:
Drugs in Context, Vol 7, Pp 1-8 (2018)
Background: Patients with ankylosing spondylitis (AS) are substantial users of healthcare resources due to chronic and potentially disabling disease. This study assessed the impact of adalimumab on clinical outcomes, healthcare resource utilizati
Externí odkaz:
https://doaj.org/article/e2396b3fb73f471ca2beef980b90c20f
Autor:
Monika Czókolyová, Anita Pusztai, Edit Végh, Ágnes Horváth, Anita Szentpéteri, Attila Hamar, Szilvia Szamosi, Katalin Hodosi, Andrea Domján, Sándor Szántó, György Kerekes, Ildikó Seres, Mariann Harangi, György Paragh, Éva Szekanecz, Zoltán Szekanecz, Gabriella Szűcs
Publikováno v:
Biomolecules, Vol 11, Iss 10, p 1535 (2021)
Background: Cardiovascular (CV) morbidity, mortality, and metabolic syndrome are associated with rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Here, lipids and other metabolic markers in relation to vascular function and clinical markers
Externí odkaz:
https://doaj.org/article/3689591733be49cd93097ae4e004a7ea
Publikováno v:
Immunology Quaterly / Immunológia Szemle; jul2023, Vol. 15 Issue 2, p36-42, 7p